Literature DB >> 18830058

Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).

Mohamad Ali Nilforoushzadeh1, Giti Sadeghian, Fariba Jaffary, Hengameh Ziaei, Liela Shirani-Bidabad, Parvin Mahzoni.   

Abstract

Lupoid leishmaniasis is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and a chronic relapsing course, mostly caused by infection with Leishmania tropica. In this clinical form, 1-2 yr after healing of the acute lesion, new papules and nodules appear at the margin of the remaining scar. Herein, we describe a case of this clinical form that was resistant to 2 courses of treatments: systemic glucantime and then a combination therapy with allopurinol and systemic glucantime. However, marked improvement was seen after a combination therapy with topical trichloroacetic acid solution (50%) and systemic glucantime, and there were no signs of recurrence after 1 yr of follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18830058      PMCID: PMC2553342          DOI: 10.3347/kjp.2008.46.3.175

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  14 in total

1.  Treatment of cutaneous leishmaniasis using a carbon dioxide laser.

Authors:  K B Babajev; O G Babajev; V I Korepanov
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

2.  The treatment of leishmaniasis recidivans with local injections of amphotericin B.

Authors:  S Ganor
Journal:  Dermatol Int       Date:  1967 Jul-Sep

3.  Cryosurgery in cutaneous leishmaniasis.

Authors:  A Bassiouny
Journal:  Br J Dermatol       Date:  1983-11       Impact factor: 9.302

4.  Levamisole and immune response phenomena in cutaneous leishmaniasis.

Authors:  P G Butler
Journal:  J Am Acad Dermatol       Date:  1982-06       Impact factor: 11.527

5.  Studies on chronic (lupoid) leishmaniasis.

Authors:  S Ardehali; M Sodeiphy; P Haghighi; H Rezai; D Vollum
Journal:  Ann Trop Med Parasitol       Date:  1980-08

6.  [Chronic lupoid leishmaniasis. A rare differential diagnosis in Germany for erythematous infiltrative facial plaques].

Authors:  A Herrmann; J Wohlrab; H Sudeck; G-D Burchard; W C Marsch
Journal:  Hautarzt       Date:  2007-03       Impact factor: 0.751

7.  Cutaneous leishmaniasis in Sanliurfa: epidemiologic and clinical features of the last four years (1997-2000).

Authors:  Mehmet Salih Gurel; Mustafa Ulukanligil; Hatice Ozbilge
Journal:  Int J Dermatol       Date:  2002-01       Impact factor: 2.736

8.  Histological spectrum of cutaneous leishmaniasis due to Leishmania tropica.

Authors:  B Azadeh; A Samad; S Ardehali
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

9.  Treatment of recurrent cutaneous Leishmaniasis.

Authors:  A Z Momeni; M Aminjavaheri
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

10.  Standardizing chemical peel solution formulations to avoid mishaps. Great fluctuations in actual concentrations of trichloroacetic acid.

Authors:  J B Bridenstine; J F Dolezal
Journal:  J Dermatol Surg Oncol       Date:  1994-12
View more
  1 in total

1.  Synergic Effect of Allopurinol in Combination with Nitroheterocyclic Compounds against Trypanosoma cruzi.

Authors:  Ana Lia Mazzeti; Lívia de F Diniz; Karolina R Gonçalves; Ruan Schott WonDollinger; Tassiane Assíria; Isabela Ribeiro; Maria T Bahia
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.